<?xml version="1.0" encoding="UTF-8"?>
<ref id="B104-molecules-25-04078">
 <label>104.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hurd</surname>
    <given-names>Y.L.</given-names>
   </name>
   <name>
    <surname>Spriggs</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Alishayev</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Winkel</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gurgov</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kudrich</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Oprescu</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Salsitz</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial</article-title>
  <source>Am. J. Psychiatry</source>
  <year>2019</year>
  <volume>176</volume>
  <fpage>911</fpage>
  <lpage>922</lpage>
  <pub-id pub-id-type="doi">10.1176/appi.ajp.2019.18101191</pub-id>
  <?supplied-pmid 31109198?>
  <pub-id pub-id-type="pmid">31109198</pub-id>
 </element-citation>
</ref>
